KELSEY GREEFF: Open Payments
NPI 1770108805 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 28 payments from 15 companies in 2025. Trend: 2023 $594 · 2024 $782 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $88 |
| Amgen Inc. | 5 | $73 |
| Astellas Pharma US Inc | 3 | $59 |
| PFIZER INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $41 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Medtronic, Inc. | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Lundbeck LLC | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: OTEZLA, Veozah, PAXLOVID, ZEPBOUND, NEXLETOL, Ozempic, INTERSTIM, XIFAXAN.
Industry payments across GA — which companies pay providers there.
